
IndraLab
Statements
sparser
"In mice, oncostatin M receptor (OSMR) and leukemia inhibitory factor receptor (LIFR) are selectively activated by the respective cognate ligands while OSM activates both the OSMR and LIFR in humans, which prevents efficient translation of mouse data into potential clinical applications."
reach
"For example, ERK1/2, PI3K, and STAT1/3 can be activated by OSM binding the LIFR or OSMR, but only signaling through the OSMR can activate STAT5, p38, JNK, and possibly PKC-δ and STAT622.OSM has been identified as a potential therapeutic target for treatment of inflammatory diseases."
reach
"On the molecular level this usage of OSM from different species results in the stimulation of different receptor complexes : human OSM exclusively binds to the type I gp130 and LIFR system in mouse cells; murine OSM, however, exclusively activates the type II gp130 and OSMR system."
reach
"Herein, a chromatin immunoprecipitation (ChIP) assay was performed after the cells were stimulated with the ligand OSM that activates OSMR signaling in the presence or absence of STAT3 inhibitor of phosphorylation and promoter binding activity, named S3I-201 inhibitor and found that OSM stimulation enhanced the binding of STAT3 transcription factor on the promoters of ITGAV, ITGB3, and ITGB8 genes, which was abrogated when the cells were treated with S3I-201 (Fig. 4d, e and Supplementary Fig. 5a)."
reach
"Examining these 37 genes in Osmr
Mx1-Cre HSCs stimulated with OSM (Supplemental Table 3) revealed several patterns; (I) 17 genes were no longer induced by OSM in Osmr
Mx1-Cre HSCs, (II) 6 genes were induced by OSM in both control Mx1-Cre and Osmr
Mx1-Cre HSCs, and (III) 10 genes were induced by OSM in control Mx1-Cre HSCs but repressed by OSM in Osmr
Mx1-Cre HSCs."
reach
"Taken together, OSM-neutralizing therapies for peripheral immune-mediated diseases have not been successful so far, which may underscore the complex nature of this molecule and the importance of identifying the optimal therapeutic window.First, in humans, OSM can signal via the OSMR (consisting of gp130 and OSMRβ) and leukemia inhibitory factor (LIF)R (consisting of gp130 and LIFRβ), which implies that LIFR signaling might be activated when OSM is used as a drug."
reach
"Supported by LUMINEX-ELISA and RNA-Seq analyses of PCCs, PSCs, and MØ isolated from PSC–PCC and PSC–MØ–PCC co-cultures, they found that MØ-derived Oncostatin M (OSM) activated the OSM receptor (OSMR) on PSCs and stimulated expression of inflammation-related secreted ligands, which in turn induced a protumor environment to activate proliferative and migratory signaling pathways in PCCs, implying therapeutic potential by targeting the MØs–PSC–PCC interaction through OSM–OSMR complex."
reach
"In addition, HSCs with reduction or loss of OSMRβ appear to incur compensatory activation of OSM-stimulated genes indicating a more complex, tissue-dependent regulation of OSM-OSMRβ signaling than was previously understood.Future studies will be necessary to understand the mechanisms underlying tissue-dependent differences in Osmr transcript abundance and OSMRβ protein abundance in the B6;129-Osmr /J model."